Pulsed electromagnetic field therapy
Pulsed electromagnetic field therapy has been studied in 10 papers since 2021: 5 trials in people, 4 in animals, 1 review; 6 in the past year.
10 papers study it27 findingsUpdated
See all 9 papers on pulsed electromagnetic field therapy
At a glance
The findings reach people, from one lab or study. 7 independent labs in 5 countries.
“PEMF significantly increased extension peak torque compared to the SHAM group at 6-month post-intervention (p = 0.042).”
None of its findings points the other way.
- 7 independent labs in 5 countries
- Funders: Foundation for Research Support of Goias State and 6 more
- Human trial5
- Animals4
Studies in people
4 studies gave pulsed electromagnetic field therapy to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
up: Improves knee extension strength72% vs 25% increase at 6 months no change: Has no effect on lean muscle mass | Randomized trial8 weeks | 60 peopleBoth50 and olderMidlife adults; Older adults; refractory mild-to-moderate knee osteoarthritis | Journal of cachexia, sarcopenia and muscle, Jan 27, 2026 |
no change: Has no effect on atherosclerotic cardiovascular disease risk-0.16%, P=0.43 up: Improves lower extremity function+27.48%, P=0.001 | Randomized trial8 weeks | 14 people45-60 yearsMidlife adults; type 2 diabetes mellitus | American journal of cardiovascular disease, Dec 15, 2025 |
up: Improves knee extensor strength up: Improves functional performance no change: Has no effect on calf circumference | Trialfour weeks | 25 peopleElderly adults with sarcopenia | Life (Basel, Switzerland), Jul 16, 2025 |
down: Decreases pain-3.2 ± 1.2, P = .028 down: Decreases stiffness-1.4 ± 0.6, P = .038 up: Improves physical function-9.0 ± 3.6, P = .039 | Randomized trial4 months | 60 peopleolder adultsOlder adults; knee osteoarthritis | Journal of geriatric physical therapy (2001), Jan 27, 2025 |
What did studies of pulsed electromagnetic field therapy find?
25Studies of pulsed electromagnetic field therapy measured 25 outcomes, among them functional performance, knee extensor strength and bone marrow adiposity.
Functional performance
upin humans1
1 study
Functional performance
upin humans1
Pulsed electromagnetic field therapy improves functional performance in humans (sarcopenia).
“Additionally, the interaction between time and group was also significant (F1,14 = 7.521, p = 0.016; η2p = 0.349), indicating that the change in TUG performance differed between groups over the analyzed period.”
Human trialsarcopeniafour weeks
Life (Basel, Switzerland)
Pulsed electromagnetic field therapy improves functional performance in older adults with sarcopenia (from 23.1 ± 14.4 to 18.7 ± 10 s (p = 0.048)).
“TUG test time improved from 23.1 ± 14.4 to 18.7 ± 10 s (p = 0.048)”
Human trialin older adults with sarcopenia12 sessionsn = 25
Life (Basel, Switzerland)
Knee extensor strength
upin humans1
1 study
Knee extensor strength
upin humans1
Pulsed electromagnetic field therapy improves knee extensor strength in humans (sarcopenia).
“Additionally, a significant interaction effect between time and group was identified (F1,14 = 12.318, p = 0.003; η2p = 0.468), suggesting that the degree of increase in lower-limb strength over time differed between groups.”
Human trialsarcopeniaknee extensorfour weeks
Life (Basel, Switzerland)
Pulsed electromagnetic field therapy improves knee extensor strength in older adults with sarcopenia (from 13.05 ± 4.8 kgf to 18.56 ± 8 kgf (p < 0.001)).
“Significant improvements were observed in knee-extension strength, which increased from 13.05 ± 4.8 kgf to 18.56 ± 8 kgf (p < 0.001)”
Human trialin older adults with sarcopeniaquadriceps and gastrocnemius muscles12 sessionsn = 25
Life (Basel, Switzerland)
Bone marrow adiposity
downin rats1
1 study
Bone marrow adiposity
downin rats1
Pulsed electromagnetic field therapy decreases bone marrow adiposity in ovariectomized rats.
“enhanced bone formation rate, and reduced bone marrow adiposity”
Animalsin ovariectomized rats8 weeks
Bone reports
Trabecular bone mass
upin rats1
1 study
Trabecular bone mass
upin rats1
Pulsed electromagnetic field therapy improves trabecular bone mass in ovariectomized rats.
“daily PEMF exposure for 8 weeks significantly preserved trabecular bone mass and microarchitecture”
Animalsin ovariectomized rats8 weeks
Bone reports
Wnt/β-catenin signaling
upin rat cells1
1 study
Wnt/β-catenin signaling
upin rat cells1
Pulsed electromagnetic field therapy activates wnt/β-catenin signaling in dexamethasone-treated rat BMSCs.
“PEMF activates the canonical Wnt/β-catenin pathway”
Cellsin dexamethasone-treated rat BMSCs75 Hz, 1.5 mT
Bone reports
Adipogenesis
downin rat cells1
1 study
Adipogenesis
downin rat cells1
Pulsed electromagnetic field therapy decreases adipogenesis in dexamethasone-treated rat BMSCs.
“concurrently suppressing adipogenesis in vitro”
Cellsin dexamethasone-treated rat BMSCs75 Hz, 1.5 mT
Bone reports
Osteogenic differentiation
upin rat cells1
1 study
Osteogenic differentiation
upin rat cells1
Pulsed electromagnetic field therapy improves osteogenic differentiation in dexamethasone-treated rat BMSCs.
“promoting osteogenic differentiation and concurrently suppressing adipogenesis in vitro”
Cellsin dexamethasone-treated rat BMSCs75 Hz, 1.5 mT
Bone reports
Trabecular bone
upin rats1
1 study
Trabecular bone
upin rats1
Pulsed electromagnetic field therapy increases trabecular bone in a rat model of osteosarcopenia.
“We found that PEMF enhance the synthesis of osteogenic and myogenic proteins, leading to an increase in both the quantity and density of trabecular bone and myotubes.”
Animalsin a rat model of osteosarcopeniabone15 Hz, 2.0 mT12 weeksfemales
Frontiers in immunology
IL-6
downin rats1
1 study
IL-6
downin rats1
Pulsed electromagnetic field therapy decreases IL-6 in a rat model of osteosarcopenia.
“Moreover, PEMF treatment attenuated the systemic chronic inflammatory milieu, as evidenced by reduced circulating levels of IL-6 and TNF-α”
Animalsin a rat model of osteosarcopenia15 Hz, 2.0 mT12 weeksfemales
Frontiers in immunology
Muscle atrophy
downin rats1
1 study
Muscle atrophy
downin rats1
Pulsed electromagnetic field therapy decreases muscle atrophy in a rat model of osteosarcopenia.
“This intervention reduces the progression of bone loss and muscle atrophy while simultaneously improving the biological performance of muscle and bone.”
Animalsin a rat model of osteosarcopeniaskeletal muscle15 Hz, 2.0 mT12 weeksfemales
Frontiers in immunology
Lean muscle mass
no changein humans1
1 study
Lean muscle mass
no changein humans1
Pulsed electromagnetic field therapy showed no clear effect on lean muscle mass in humans (refractory mild-to-moderate knee osteoarthritis).
“Additionally, there were no differences between the PEMF and SHAM groups in lean muscle mass, cartilage thickness, mJSW, the 6-m walk time and the number of repetitions of chair standing in 30 s and WOMAC (all p > 0.05).”
Human trialrefractory mild-to-moderate knee osteoarthritis8 weeksn = 60
Journal of cachexia, sarcopenia and muscle
Knee extension strength
upin humans1
1 study
Knee extension strength
upin humans1
Pulsed electromagnetic field therapy improves knee extension strength in humans (refractory mild-to-moderate knee osteoarthritis) (72% vs 25% increase at 6 months).
“PEMF significantly increased extension peak torque compared to the SHAM group at 6-month post-intervention (p = 0.042).”
Human trialrefractory mild-to-moderate knee osteoarthritis8 weeksn = 60
Journal of cachexia, sarcopenia and muscle
Lower extremity function
upin humans1
1 study
Lower extremity function
upin humans1
Pulsed electromagnetic field therapy improves lower extremity function in humans (type 2 diabetes mellitus) (+27.48%, P=0.001).
“lower extremity function significantly increased by 64.62% (P<0.001), 27.48% (P=0.001), and 48.49% (P<0.001) in groups A, B, and C, respectively”
Human trialtype 2 diabetes mellitus8 weeksn = 14
American journal of cardiovascular disease
Atherosclerotic cardiovascular disease risk
no changein humans1
1 study
Atherosclerotic cardiovascular disease risk
no changein humans1
Pulsed electromagnetic field therapy showed no clear effect on atherosclerotic cardiovascular disease risk in humans (type 2 diabetes mellitus) (-0.16%, P=0.43).
“non-significantly decreased by -0.16% (P=0.43) in group B”
Human trialtype 2 diabetes mellitus8 weeksn = 14
American journal of cardiovascular disease
Depressive symptoms
downin humans1
1 study
Depressive symptoms
downin humans1
Pulsed electromagnetic field therapy decreases depressive symptoms in humans (sarcopenia) (7.9 ± 2.4 to 5.4 ± 1.7).
“PEMF treatment led to a significant reduction in the individual scores (7.9 ± 2.4 to 5.4 ± 1.7), indicating an improvement in the depressive state (p = 0.0013). shows the effects of PEMF treatment pre- and post-intervention.”
Human trialsarcopeniafour weeksn = 25
Life (Basel, Switzerland)